- 貨號 Cat. No.
- S1237
- 規格 Size
- 10mM/1mLã€100mg
- 品牌 Brand
- Selleckchem
Description
Temozolomide
Temozolomide is a DNA damage inducer.
Size |
Price |
Stock |
Quantity |
|
|---|
10mM/1mLIn DMSO |
USD 80 |
In stock |
0
1
2
3
4
5
6
7
8
9
10
|
25mg |
USD 88 |
In stock |
0
1
2
3
4
5
6
7
8
9
10
|
100mg |
USD 214 |
In stock |
0
1
2
3
4
5
6
7
8
9
10
|
|
Distributor Tel: +886-2-2827-1197jimmy@new.abscience.com.tw
Biological Activity
Description |
Temozolomide is a DNA damage inducer. |
|---|
Targets |
|
|
|
|
|
|
|---|
IC50 |
|
|
|
|
|
|
|---|
In vitro |
Methazolastone causes formation of DNA alkali-labile sites which are present in similar amounts and repaired at a similar rate in L-1210 and L-1210/BCNU. In L-1210 but not in L-1210/BCNU methazolastone induces an arrest of cells in SL-G2-M phases. Methazolastone induces a similar amount of DNA ALS which is also repaired at a similar rate in L-1210 and L-1210/BCNU cell lines. Methazolastone induces a similar amount of DNA ALS which is also repaired at a similar rate in L-1210 and L-1210/BCNU cell lines. [1] Methazolastone sensitivity of both chemo-sensitive and resistant cells (D54-R and U87-R) is enhanced significantly under hyperoxia. Both Methazolastone and hyperoxia are associated with increased phosphorylation of ERK p44/42 MAPK (Erk1/2), but to a lesser extent in D54-R cells, suggesting that Erk1/2 activity may be involved in regulation of hyperoxia and Methazolastone-mediated cell death. Hyperoxia enhances Methazolastone toxicity in GBM cells by induction of apoptosis, possibly via MAPK-related pathways. [2] Methazolastone induces in monocytes the DNA damage response pathways ATM-Chk2 and ATR-Chk1 resulting in p53 activation. [3] Chronic Methazolastone exposure results in acquired Methazolastone-resistance and elevates miR-21 expression. [4]Methazolastone treatment triggers endoplasmic reticula (ER) stress with increased expression of GADD153 and GRP78 proteins, and deceases pro-caspase 12 protein. Methazolastone induces autophagy through mitochondrial damage- and ER stress-dependent mechanisms to protect glioma cells. [5] |
|---|
In vivo |
After a daily i.p. dose of 40 mg/kg for 5 consecutive days (days 1-5 after tumor transplant), methazolastone increases life-span by 86% in L-1210 and 22% in L-1210/BCNU. In L-1210/BCNU no effect is seen after 100 μM or 200 μM treatment; only 400 μM methazolastone produced an accumulation of cells in premitotic phase but much less than in L-1210. In L-1210/BCNU the maximum accumulation of cells in SL-G2-M is, after 48 hours-72 hours, approximately 30% as compared to 23% in untreated cells. Cells accumulates in SL-G2-M occurred too when L- 1210 leukemia-bearing mice are treated i.v. with methazola stone (40 mg/kg). No such effect is seen on L-1210/BCNU cells from mice given the same drug dose. [1] |
|---|
Features |
Methazolastone is a second-generation alkylating agent. |
|---|
Protocol(Only for Reference)
Cell Assay: [1]
Cell lines |
L-1210 and L-1210/BCNU cells |
|---|
Concentrations |
0 μM -100 μM |
|---|
Incubation Time |
l hours |
|---|
Method |
L-1210 and L-1210/BCNU cells are seeded at 0.2 × 104 cells/mL and incubated for 24 hours. The cultures are treated with Methazolastone for l hours at 37oC, then washed twice in PBS by centrifugation and resuspended in fresh medium. Controls and treated samples are diluted in fresh medium 1:4 at 48 hours and 1:2 at 96 hours. Using these dilutions cell concentrations throughout the experiments are between 3 × 105 and 8 × 105/mL. Control growth is logarithmic in this range. |
|---|
Animal Study: [1]
Animal Models |
DBA/2 mice with L-1210 and L-1210/BCNU cells |
|---|
Dosages |
40 mg/kg |
|---|
Administration |
Administered via i.v. |
|---|
Solubility |
1% DMSO/30% polyethylene glycol/1% Tween 80, 30 mg/mL |
|---|
1
References
Download Temozolomide SDF
Molecular Weight (MW) |
194.15 |
|---|
Formula |
C6H6N6O2
|
|---|
CAS No. |
85622-93-1 |
|---|
Storage |
3 years -20℃Powder |
|---|
6 months-80℃in DMSO |
Syonnyms |
Methazolastone, Temodar, Temodal |
|---|
Solubility (25°C) * |
In vitro |
DMSO |
39 mg/mL (200 mM) |
|---|
Water |
5 mg/mL (25 mM) |
Ethanol |
<1 mg/mL (<1 mM) |
In vivo |
1% DMSO/30% polyethylene glycol/1% Tween 80, |
30 mg/mL |
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Stock Solution (1ml DMSO) |
1mM |
10mM |
20mM |
30mM |
|---|
Mass(mg) |
0.19415 |
1.9415 |
3.883 |
5.8245 |
Product Citations (1)
詢價 / 洽詢此產品